SOLV vs WST: stock comparison and AI forecast
Solventum Corp (SOLV) and West Pharmaceutical Services Inc (WST) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
SOLV Solventum Corp
- Market Cap
- $14.84B
- P/E Ratio
- 80.7x
- Size
- large-cap
- AI Forecast
WST West Pharmaceutical Services Inc
- Market Cap
- $27.34B
- P/E Ratio
- 44.1x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- WST is 1.8 times larger than SOLV by market capitalization ($27.34B against $14.84B).
- WST trades at 44.0 times trailing earnings, SOLV at 80.7 times.
- WST turns 18.8% of its revenue into net income, against 1.9% for SOLV.
- SOLV carries 1.95 times debt per unit of equity, against 0.37 times for WST.
- WST yields 0.23% in dividends; SOLV pays none.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | SOLV | WST |
|---|---|---|
| Market Cap | $14.84B | $27.34B |
| P/E Ratio | 80.72x | 44.05x |
| P/B Ratio | 3.09x | 9.21x |
| Dividend Yield | – | 0.23% |
| EPS | $1.08 | $8.91 |
| Book Value/Share | $28.23 | $42.61 |
| Revenue/Share | $47.95 | $48.76 |
| FCF/Share | $0.00 | $6.51 |
Profitability & Margins
| Metric | SOLV | WST |
|---|---|---|
| ROE | 3.2% | 21.5% |
| ROA | 1.1% | 15.7% |
| ROIC | 4.3% | 22.8% |
| Gross Margin | 54.8% | 37.6% |
| Operating Margin | 5.6% | 23.0% |
| Net Margin | 1.9% | 18.8% |
| EBT Margin | 2.1% | 23.2% |
| Tax Rate | 8.2% | 21.3% |
Financial Health
| Metric | SOLV | WST |
|---|---|---|
| Current Ratio | 1.03x | 2.82x |
| Quick Ratio | 0.72x | 2.10x |
| D/E Ratio | 1.95x | 0.37x |
| Financial Leverage | 2.95x | 1.37x |
| Interest Coverage | 0.3x | 10.4x |
| Working Capital | $117M | $1.17B |
Cash Flow
| Metric | SOLV | WST |
|---|---|---|
| Operating Cash Flow | $310M | $654M |
| Free Cash Flow | $0.00M | $453M |
| Capital Spending | -$310M | -$201M |
| OCF Growth YoY | -37.1% | -5.7% |
| FCF Growth YoY | -100.0% | 19.6% |
| FCF/Sales | 0.0% | 13.3% |
| CapEx/Sales | 3.8% | 5.9% |
Operational Efficiency
| Metric | SOLV | WST |
|---|---|---|
| Asset Turnover | 0.58x | 0.84x |
| Receivables Turnover | 6.0x | 4.5x |
| Inventory Turnover | 3.4x | 4.6x |
| Fixed Assets Turnover | 5.9x | 2.0x |
| Days Sales Outstanding | 61 days | 80 days |
| Days Inventory | 109 days | 80 days |
| Payables Period | 80 days | 43 days |
| Cash Conversion Cycle | 90 days | 117 days |
Income Statement
| Metric | SOLV | WST |
|---|---|---|
| Total Revenue | $8.16B | $3.40B |
| Operating Income | $455M | $780M |
| Net Income | $156M | $639M |
| R&D Expense | $722M | $76M |
| SG&A Expense | $3.33B | $437M |
| Cost of Goods Sold | $3.69B | $2.12B |
Dividend & Shareholder Information
| Metric | SOLV | WST |
|---|---|---|
| Dividends Per Share | – | $0.90 |
| Payout Ratio | – | 10.1% |
| Shares Outstanding | 170M | 70M |
| Net Income Growth | -89.8% | 29.9% |
| EPS Growth | -86.3% | 32.0% |
SOLV vs WST: stock comparison and AI forecast
Which is bigger, SOLV or WST?
WST is 1.8 times larger than SOLV by market capitalization ($27.34B against $14.84B).
Which is cheaper on earnings, SOLV or WST?
WST trades at 44.0 times trailing earnings, SOLV at 80.7 times.
Which one does Intratio's AI model rank higher, SOLV or WST?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.